首页> 美国卫生研究院文献>Journal of Pharmaceutical Analysis >New simple spectrophotometric method for determination of the binary mixtures (atorvastatin calcium and ezetimibe; candesartan cilexetil and hydrochlorothiazide) in tablets
【2h】

New simple spectrophotometric method for determination of the binary mixtures (atorvastatin calcium and ezetimibe; candesartan cilexetil and hydrochlorothiazide) in tablets

机译:新的简单分光光度法测定片剂中的二元混合物(阿托伐他汀钙和依折麦布;坎地沙坦西拉克司和氢氯噻嗪)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A new simple spectrophotometric method was developed for the determination of binary mixtures without prior separation. The method is based on the generation of ratio spectra of compound X by using a standard spectrum of compound Y as a divisor. The peak to trough amplitudes between two selected wavelengths in the ratio spectra are proportional to concentration of X without interference from Y. The method was demonstrated by determination of two drug combinations. The first consists of the two antihyperlipidemics: atorvastatin calcium (ATV) and ezetimibe (EZE), and the second comprises the antihypertensives: candesartan cilexetil (CAN) and hydrochlorothiazide (HCT). For mixture 1, ATV was determined using 10 μg/mL EZE as the divisor to generate the ratio spectra, and the peak to trough amplitudes between 231 and 276 nm were plotted against ATV concentration. Similarly, by using 10 μg/mL ATV as divisor, the peak to trough amplitudes between 231 and 276 nm were found proportional to EZE concentration. Calibration curves were linear in the range 2.5–40 μg/mL for both drugs. For mixture 2, divisor concentration was 7.5 μg/mL for both drugs. CAN was determined using its peak to trough amplitudes at 251 and 277 nm, while HCT was estimated using the amplitudes between 251 and 276 nm. The measured amplitudes were linearly correlated to concentration in the ranges 2.5–50 and 1–30 μg/mL for CAN and HCT, respectively. The proposed spectrophotometric method was validated and successfully applied for the assay of both drug combinations in several laboratory-prepared mixtures and commercial tablets.
机译:开发了一种新的简单分光光度法,无需事先分离即可测定二元混合物。该方法基于通过使用化合物Y的标准光谱作为除数来产生化合物X的比率光谱。比率光谱中两个选定波长之间的峰谷幅度与X的浓度成正比,而不受Y的干扰。该方法通过确定两种药物组合来证明。第一种由两种降血脂药组成:阿托伐他汀钙(ATV)和依泽替米贝(EZE),第二种由抗高血压药:坎地沙坦西酯(CAN)和氢氯噻嗪(HCT)组成。对于混合物1,使用10μg/ mL EZE作为除数来确定ATV以生成比率光谱,并针对ATV浓度绘制231至276 nm之间的峰谷幅度。同样,通过使用10μg/ mL ATV作为除数,发现231至276 nm之间的峰谷幅度与EZE浓度成正比。两种药物的校准曲线在2.5–40μg / mL范围内呈线性关系。对于混合物2,两种药物的除数浓度均为7.5μg/ mL。使用其峰谷在251和277nm处的波谷幅度确定CAN,而使用阈值在251和276 nm之间的幅度估计HCT。对于CAN和HCT,测得的振幅分别与浓度在2.5–50和1–30μg / mL范围内线性相关。所提出的分光光度法经过验证,并成功地用于测定几种实验室制备的混合物和市售片剂中的两种药物组合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号